Literature DB >> 15918515

Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule.

Sun Young Park1, Jong-Keun Kim, In Jin Kim, Bong Kyu Choi, Kyu Yong Jung, Seoul Lee, Kyung Jin Park, Arthit Chairoungdua, Yoshikatsu Kanai, Hitoshi Endou, Do Kyung Kim.   

Abstract

In order to understand the renal reabsorption mechanism of neutral amino acids via amino acid transporters, we have isolated human L-type amino acid transporter 2 (hLAT2) and human T-type amino acid transporter 1 (hTAT1) in human, then, we have examined and compared the gene structures, the functional characterizations and the localization in human kidney. Northern blot analysis showed that hLAT2 mRNA was expressed at high levels in the heart, brain, placenta, kidney, spleen, prostate, testis, ovary, lymph node and the fetal liver. The hTAT1 mRNA was detected at high levels in the heart, placenta, liver, skeletal muscle, kidney, pancreas, spleen, thymus and prostate. Immunohistochemical analysis on the human kidney revealed that the hLAT2 and hTAT1 proteins coexist in the basolateral membrane of the renal proximal tubules. The hLAT2 transports all neutral amino acids and hTAT1 transports aromatic amino acids. The basolateral location of the hLAT2 and hTAT1 proteins in the renal proximal tubule as well as the amino acid transport activity of hLAT2 and hTAT1 suggests that these transporters contribute to the renal reabsorption of neutral and aromatic amino acids in the basolateral domain of epithelial proximal tubule cells, respectively. Therefore, LAT2 and TAT1 play essential roles in the reabsorption of neutral amino acids from the epithelial cells to the blood stream in the kidney. Because LAT2 and TAT1 are essential to the efficient absorption of neutral amino acids from the kidney, their defects might be involved in the pathogenesis of disorders caused by a disruption in amino acid absorption such as blue diaper syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918515     DOI: 10.1007/BF02977671

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  17 in total

1.  Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Authors:  Fredrick J Rosario; Michael A Schumacher; Jean Jiang; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

Review 2.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

3.  Protein kinase C activation upregulates human L-type amino acid transporter 2 function.

Authors:  Hanae Morio; Yoshie Reien; Yuri Hirayama; Hirofumi Hashimoto; Naohiko Anzai
Journal:  J Physiol Sci       Date:  2021-03-31       Impact factor: 2.781

4.  News from the dark side!

Authors:  David T Thwaites
Journal:  J Physiol       Date:  2012-12-15       Impact factor: 5.182

5.  Down-regulation of placental mTOR, insulin/IGF-I signaling, and nutrient transporters in response to maternal nutrient restriction in the baboon.

Authors:  Jovita V Kavitha; Fredrick J Rosario; Mark J Nijland; Thomas J McDonald; Guoyao Wu; Yoshikatsu Kanai; Theresa L Powell; Peter W Nathanielsz; Thomas Jansson
Journal:  FASEB J       Date:  2013-12-13       Impact factor: 5.191

Review 6.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.

Authors:  Malte Selch Larsen; Sidsel Frølund; Martha Kampp Nøhr; Carsten Uhd Nielsen; Mats Garmer; Mads Kreilgaard; René Holm
Journal:  Pharm Res       Date:  2014-09-03       Impact factor: 4.200

8.  Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.

Authors:  Fredrick J Rosario; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-11-19       Impact factor: 5.182

9.  T-type amino acid transporter TAT1 (Slc16a10) is essential for extracellular aromatic amino acid homeostasis control.

Authors:  Luca Mariotta; Tamara Ramadan; Dustin Singer; Adriano Guetg; Brigitte Herzog; Claudia Stoeger; Manuel Palacín; Tony Lahoutte; Simone M R Camargo; François Verrey
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

10.  Regulation of amino acid transporter trafficking by mTORC1 in primary human trophoblast cells is mediated by the ubiquitin ligase Nedd4-2.

Authors:  Fredrick J Rosario; Kris Genelyn Dimasuay; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  Clin Sci (Lond)       Date:  2015-11-25       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.